The Minnesota Department of Health (MDH) supports the inclusion of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) as an evidence-based intervention to prevent HIV transmission. The primary goal of PrEP is to reduce new HIV transmission among people who are at a high risk for acquiring HIV and continues efforts to increase access to these lifesaving interventions and reduce new HIV infections in the state.

Pre-Exposure Prophylaxis (PrEP): The daily use of an antiretroviral medication (tenofovir/emtiricitabine, brand name Truvada) to prevent HIV infection by uninfected persons.
Post-Exposure Prophylaxis (PEP): Taking antiretroviral medications after an HIV exposure to reduce the chances of becoming infected. This is also referred to as nPEP, for non-occupational post-exposure prophylaxis.

We are compiling a voluntary directory of PrEP/PEP providers. Please fill out this survey to be listed on the MDH website.

Questions marked with an asterisk (*) are required.

Clinic Information

Please provide the following:
Please provide a contact name and email address in case we need to contact you about the directory. This information will not be shared by MDH or published online.


Do you currently prescribe PrEP?*
Do you currently prescribe PEP?*
Do you have any special directions for patients when calling for PrEP/PEP?


I understand that participation in this public directory is voluntary. I understand that by sharing the information above, I am agreeing to have this information be publicly listed on the MDH website (with the exception of the contact name and email address). I understand that inclusion in this directory does not confer any endorsement by MDH nor does it establish MDH credentialing or certification in a specialty.

I agree with the above statement*
100% Complete